{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:12:52Z","timestamp":1791216772008,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China Project","award":["2023YFC2308102"],"award-info":[{"award-number":["2023YFC2308102"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130019"],"award-info":[{"award-number":["82130019"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11876-5","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:22:57Z","timestamp":1763022177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Chenyang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"11876_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C, Gonzalez MA, Sabry Alaama A, Mozalevskis A, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8:332\u201342.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11876_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"OC Polaris","year":"2023","unstructured":"Polaris OC. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8:879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11876_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, et al. Hepatitis c virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4:477\u201387.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11876_CR4","doi-asserted-by":"publisher","first-page":"1315392","DOI":"10.3389\/fpubh.2023.1315392","volume":"11","author":"C Huang","year":"2023","unstructured":"Huang C, Wu Y, Zhang C, Ji D, Wang FS. The burden of cirrhosis and other chronic liver diseases due to hepatitis B in children and adolescents: results from global burden of disease study 2019. Front Public Health. 2023;11:1315392.","journal-title":"Front Public Health"},{"key":"11876_CR5","first-page":"00","volume":"00","author":"F-SZS Wang","year":"2024","unstructured":"Wang F-SZS, Xu X. Expert consensus on the prevention and treatment of chronic hepatitis b in children. Infect Dis Immun. 2024;00:00\u201300.","journal-title":"Infect Dis Immun"},{"key":"11876_CR6","first-page":"1425","volume":"11","author":"H You","year":"2023","unstructured":"You H, Wang F, Li T, Xu X, Sun Y, Nan Y, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Clin Transl Hepatol. 2023;11:1425\u201342.","journal-title":"J Clin Transl Hepatol"},{"key":"11876_CR7","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560\u201399.","journal-title":"Hepatology"},{"key":"11876_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jhep.2013.05.016","volume":"59","author":"EM Sokal","year":"2013","unstructured":"Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology. Hepatol Nutr J Hepatol. 2013;59:814\u201329.","journal-title":"Hepatol Nutr J Hepatol"},{"key":"11876_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijid.2022.08.017","volume":"123","author":"Y Hu","year":"2022","unstructured":"Hu Y, Wu X, Ye Y, Ye L, Han S, Wang X, et al. Liver histology of treatment-naive children with chronic hepatitis B virus infection in Shanghai China. Int J Infect Dis. 2022;123:112\u20138.","journal-title":"Int J Infect Dis"},{"key":"11876_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"11876_CR11","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-94.","journal-title":"Ann Intern Med"},{"key":"11876_CR12","unstructured":"Chinese Society of Infectious Diseases CMA, Chinese Society of Hepatology CMA, Group of Infectious Diseases CPSCMA, National Clinical Research Center for Infectious D. Research progress on clinical antiviral treatment of chronic hepatitis B in children. Zhonghua Gan Zang Bing Za Zhi. 2024;32:435\u2013448."},{"key":"11876_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598\u2013607.","journal-title":"J Hepatol"},{"key":"11876_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696\u20139.","journal-title":"J Hepatol"},{"key":"11876_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431\u20135.","journal-title":"Hepatology"},{"key":"11876_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"11876_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.3122\/jabfm.2012.02.120023","volume":"25","author":"D Meyers","year":"2012","unstructured":"Meyers D. Introduction from the agency for healthcare research and quality. J Am Board Fam Med. 2012;25(Suppl 1):S1.","journal-title":"J Am Board Fam Med"},{"key":"11876_CR18","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P.The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.Ottawa: Ottawa Hospital Research Institute; 2011. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"11876_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974\u20138.","journal-title":"J Epidemiol Community Health"},{"key":"11876_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"11876_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"11876_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1097\/MEG.0b013e328317f1fe","volume":"21","author":"I Mozer-Lisewska","year":"2009","unstructured":"Mozer-Lisewska I, Mania A, Sluzewski W, Kemnitz P, Prusinowska J, Kowala-Piaskowska A, et al. Factors influencing clinical course and histological findings in children with chronic hepatitis b. Eur J Gastroenterol Hepatol. 2009;21:1400\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"11876_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MPG.0000000000002712","volume":"71","author":"N Rodriguez-Baez","year":"2020","unstructured":"Rodriguez-Baez N, Murray KF, Kleiner DE, Ling SC, Rosenthal P, Carlin K, et al. Hepatic histology in treatment-naive children with chronic hepatitis B infection living in the United States and Canada. J Pediatr Gastroenterol Nutr. 2020;71:99\u2013105.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"11876_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00535-019-01594-6","volume":"54","author":"L Wang","year":"2019","unstructured":"Wang L, Wang Y, Liu S, Zhai X, Zhou G, Lu F, et al. Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population. J Gastroenterol. 2019;54:1096\u2013105.","journal-title":"J Gastroenterol"},{"key":"11876_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3109\/00365541003774616","volume":"42","author":"S Sokucu","year":"2010","unstructured":"Sokucu S, Gokce S, Gulluoglu M, Aydogan A, Celtik C, Durmaz O. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naive chronic hepatitis B infection. Scand J Infect Dis. 2010;42:699\u2013703.","journal-title":"Scand J Infect Dis"},{"key":"11876_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12879-022-07142-7","volume":"22","author":"H Luo","year":"2022","unstructured":"Luo H, Peng S, Ouyang W, Tan Y, Jiang T, Tang L, et al. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection. BMC Infect Dis. 2022;22:160.","journal-title":"BMC Infect Dis"},{"key":"11876_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.17219\/acem\/60535","volume":"25","author":"MK-MB Pokorska-\u015apiewak","year":"2016","unstructured":"Pokorska-\u015apiewak MK-MB, Aniszewska M, Pluta M, Walewska-Zielecka B, Marczy\u0144ska M. Predictors of liver disease severity in children with chronic hepatitis B. Adv Clin Exp Med. 2016;25:681\u20138.","journal-title":"Adv Clin Exp Med"},{"key":"11876_CR28","doi-asserted-by":"publisher","first-page":"e26462","DOI":"10.1097\/MD.0000000000026462","volume":"100","author":"KL Zhang","year":"2021","unstructured":"Zhang KL, Chen XQ, Lv ZL, Tang Q, Shan QW. A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B. Medicine (Baltimore). 2021;100:e26462.","journal-title":"Medicine (Baltimore)"},{"key":"11876_CR29","unstructured":"Liang CF, Chang YN, Peng XR, He Y, Chen M, Peng ML, Hu P, et al. Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi. 2021;29:551-557."},{"key":"11876_CR30","unstructured":"Melike Emiroglu AY, Meltem Gumus , Halil Haldun Emiroglu Clinical and laboratory features of children with chronic hepatitis B infection: a single center results. Turk J Gastroenterol. 2019;;30(11):995\u20131001."},{"key":"11876_CR31","first-page":"38","volume":"5","author":"PKM-LAMMW S\u0142uzewski","year":"2009","unstructured":"S\u0142uzewski PKM-LAMMW. Clinical importance of transcutaneous needle biopsy of the liver in children with chronic hepatitis B. Experimental & Clinical Hepatology. 2009;5:38\u201343.","journal-title":"Experimental & Clinical Hepatology"},{"key":"11876_CR32","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.3748\/wjg.v11.i45.7192","volume":"11","author":"DM Lebensztejn","year":"2005","unstructured":"Lebensztejn DM, Skiba E, Tobolczyk J, Sobaniec-Lotowska ME, Kaczmarski M. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol. 2005;11:7192\u20136.","journal-title":"World J Gastroenterol"},{"key":"11876_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hepres.2005.10.008","volume":"34","author":"I Mozer-Lisewska","year":"2006","unstructured":"Mozer-Lisewska I, Sluzewski W, Mania A, Walewska-Zielecka B, Bujnowska A, Kowala-Piaskowska A, et al. Histopathological evaluation of liver biopsy specimens in children with chronic hepatitis B. Hepatol Res. 2006;34:9\u201314.","journal-title":"Hepatol Res"},{"key":"11876_CR34","unstructured":"Schwarzenberg KMNR-BDKMSKCSLPRKSS. Liver histology in North American children with immune-active chronic hepatitis B Infection. Hepatology. 2016;64:57A."},{"key":"11876_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.510290230","volume":"29","author":"M Ruiz-Moreno","year":"1999","unstructured":"Ruiz-Moreno M, Otero M, Millan A, Castillo I, Cabrerizo M, Jimenez FJ, et al. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology. 1999;29:572\u20135.","journal-title":"Hepatology"},{"key":"11876_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00774-010-0219-7","volume":"29","author":"J Konstantynowicz","year":"2011","unstructured":"Konstantynowicz J, Lebensztejn DM, Skiba E, Sobaniec-Lotowska ME, Abramowicz P, Piotrowska-Jastrzebska J, et al. Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children. J Bone Miner Metab. 2011;29:315\u201320.","journal-title":"J Bone Miner Metab"},{"key":"11876_CR37","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/hep.21077","volume":"43","author":"F Bortolotti","year":"2006","unstructured":"Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43:556\u201362.","journal-title":"Hepatology"},{"key":"11876_CR38","first-page":"395","volume":"3","author":"HF Zhang","year":"2004","unstructured":"Zhang HF, Yang XJ, Zhu SS, Zhao JM, Zhang TH, Xu ZQ, et al. Pathological changes and clinical manifestations of 1020 children with liver diseases confirmed by biopsy. Hepatobiliary Pancreat Dis Int. 2004;3:395\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"11876_CR39","doi-asserted-by":"publisher","first-page":"F456","DOI":"10.1136\/adc.2002.009837","volume":"89","author":"EH Boxall","year":"2004","unstructured":"Boxall EH, Sira J, Standish RA, Davies P, Sleight E, Dhillon AP, et al. Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed. 2004;89:F456-460.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"11876_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0168-8278(98)80002-0","volume":"29","author":"F Bortolotti","year":"1998","unstructured":"Bortolotti F, Jara P, Crivellaro C, Hierro L, Cadrobbi P, Frauca E, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol. 1998;29:184\u201390.","journal-title":"J Hepatol"},{"key":"11876_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1086\/341508","volume":"186","author":"G Marx","year":"2002","unstructured":"Marx G, Martin SR, Chicoine JF, Alvarez F. Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis. 2002;186:295\u2013301.","journal-title":"J Infect Dis"},{"key":"11876_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jpeds.2003.11.022","volume":"144","author":"WH Wen","year":"2004","unstructured":"Wen WH, Chang MH, Hsu HY, Ni YH, Chen HL. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. J Pediatr. 2004;144:397\u20139.","journal-title":"J Pediatr"},{"key":"11876_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/apt.17272","volume":"57","author":"J Wang","year":"2023","unstructured":"Wang J, Yan X, Zhu L, Liu J, Qiu Y, Li Y, et al. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Aliment Pharmacol Ther. 2023;57:464\u201374.","journal-title":"Aliment Pharmacol Ther"},{"key":"11876_CR44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/apt.13488","volume":"43","author":"Y Li","year":"2016","unstructured":"Li Y, Huang YS, Wang ZZ, Yang ZR, Sun F, Zhan SY, et al. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2016;43:458\u201369.","journal-title":"Aliment Pharmacol Ther"},{"key":"11876_CR45","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/17474124.2019.1686975","volume":"13","author":"MWCM Lai","year":"2019","unstructured":"Lai MWCM. Updates in the management of hepatitis B in children. Expert Rev Gastroenterol Hepatol. 2019;13:1065\u201376.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"11876_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cgh.2022.02.046","volume":"21","author":"JFTC Wu","year":"2023","unstructured":"Wu JFTC, Chang KC, Chen HL, Ni YH, Hsu HY, Chang MH. Baseline hepatitis B virus surface antigen titers in childhood predict the risk of advanced liver fibrosis in adulthood. Clin Gastroenterol Hepatol. 2023;21:663\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11876_CR47","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.21037\/tp-22-496","volume":"12","author":"Y Hu","year":"2023","unstructured":"Hu Y, Wu X, Ye Y, Ye L, Han S, Wang X, et al. Liver histological reversibility of lamivudine in treatment-naive children with chronic hepatitis B: a retrospective cohort study from a single center Shanghai China. Transl Pediatr. 2023;12:1121\u20139.","journal-title":"Transl Pediatr"},{"key":"11876_CR48","first-page":"1218","volume":"29","author":"M Zhang","year":"2021","unstructured":"Zhang M, Li J, Wang FS. [Antiviral therapy and clinical cure for chronic hepatitis B in children: progress and challenges]. Zhonghua Gan Zang Bing Za Zhi. 2021;29:1218\u201323.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"11876_CR49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12876-022-02570-w","volume":"22","author":"A ElShahawy","year":"2022","unstructured":"ElShahawy A, El-Raziky MS, Sharaf SA, Elsharkawy A, Enayet A, Taher H. Accuracy of noninvasive methods for the diagnosis of liver fibrosis in children with chronic viral hepatitis. BMC Gastroenterol. 2022;22:508.","journal-title":"BMC Gastroenterol"},{"key":"11876_CR50","unstructured":"Zhu SS, Dong Y, Xu ZQ, Wang LM, Chen DW, Gan Y, Wang FC, et al. A retrospective study on HBsAg clearance rate after antiviral therapy in children with HBeAg-positive chronic hepatitis B aged 1\u20137 years. Zhonghua Gan Zang Bing Za Zhi. 2016;24:738\u2013743."},{"key":"11876_CR51","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/apt.17667","volume":"58","author":"XYZ Wu","year":"2023","unstructured":"Wu XYZ, Lai X, Gu Y, Peng S. Age at treatment initiation predicts response in children with chronic hepatitis B. Aliment Pharmacol Ther. 2023;58:866\u201373.","journal-title":"Aliment Pharmacol Ther"},{"key":"11876_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0016-5085(90)90972-4","volume":"99","author":"F Bortolotti","year":"1990","unstructured":"Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology. 1990;99:805\u201310.","journal-title":"Gastroenterology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11876-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11876-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11876-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:04:08Z","timestamp":1763024648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11876-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11876"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11876-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1570"}}